Skip to content
GenoLensGenoLens

ASS1

Chr 9q34.11

argininosuccinate synthase 1

Aliases:
CTLN1
MANE:
ENST00000352480.10

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Hyperammonaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

Disease associations (Open Targets)

  • citrullinemia type I

    0.86
  • citrullinemia

    0.75
  • hereditary disease

    0.47
  • acute neonatal citrullinemia type I

    0.37
  • Intellectual disability

    0.37
  • adult-onset citrullinemia type I

    0.37
  • citrullinemia type II

    0.36
  • disturbances of sensation of smell and taste

    0.34
  • autoimmune disorder of central nervous system

    0.33
  • alcohol drinking

    0.30

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Argininosuccinate synthase

One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.